Actively Recruiting
Ablation Strategies for Persistent Atrial Fibrillation Combined With Heart Failure
Led by Qianfoshan Hospital · Updated on 2024-06-03
130
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
(1) To evaluate the efficacy and safety of "2C3L" strategy combined with VOM anhydrous ethanol chemical ablation for persistent atrial fibrillation complicated with heart failure; (2) To evaluate the effectiveness of high-efficiency ablation of atrial fibrillation complicated with heart failure.
CONDITIONS
Official Title
Ablation Strategies for Persistent Atrial Fibrillation Combined With Heart Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years
- First ablation procedure for non-valvular atrial fibrillation
- Persistent atrial fibrillation with left ventricular ejection fraction (LVEF) 40% or less
- Symptoms related to atrial fibrillation such as palpitations, syncope, fatigue, or shortness of breath with NYHA class II to IV heart function
- No response or intolerance to antiarrhythmic drugs, or unwillingness to take them
You will not qualify if you...
- Paroxysmal atrial fibrillation
- Atrial fibrillation caused by clear reversible conditions
- Left atrial diameter of 60 mm or more by echocardiography
- Left ventricular ejection fraction greater than 40%
- Receiving dual antithrombotic therapy
- Contraindications to oral anticoagulants
- Contraindications to right or left heart catheterization
- Pregnancy
- Life expectancy less than 1 year due to conditions like advanced cancer or kidney disease
- Unable to stop antiarrhythmic drugs for reasons other than atrial fibrillation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hesheng Hu
Jinan, Shandong, China, 250012
Actively Recruiting
Research Team
H
Hesheng Hu
CONTACT
X
Xinran Li
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here